@article{44bdfe7329974d4495d7cbb0bcc316b6,
title = "Promote or Prevent? Gut Microbial Function and Immune Status May Determine the Effect of Fiber in Inflammatory Bowel Disease",
author = "Andrea Shin and Kashyap, {Purna C.}",
note = "Funding Information: Conflicts of interest The authors disclose the following: A.S. serves on Ardelyx Scientific Communications Advisory Board for irritable bowel syndrome with constipation. P.C.K. is an ad hoc consultant for Pendulum Therapeutics, IP Group Inc., and Intrinsic Medicine. P.C.K. holds the patent US20170042860A1 “Methods and materials for using Ruminococcus gnavus or Clostridium sporogenes to treat gastrointestinal disorders” for use of tryptamine producing bacteria to treat gastrointestinal disorders. Mayo Clinic and P.C.K. have a financial interest related to use of tryptamine-producing bacteria. Funding A.S. is supported by NIDDK K23DK122015, R03DK132446. P.C.K. is supported by NIH R01DK114007. Funding Information: Funding A.S. is supported by NIDDK K23DK122015, R03DK132446. P.C.K. is supported by NIH R01DK114007. ",
year = "2023",
month = feb,
doi = "10.1053/j.gastro.2022.11.022",
language = "English (US)",
volume = "164",
pages = "182--184",
journal = "Gastroenterology",
issn = "0016-5085",
publisher = "W.B. Saunders Ltd",
number = "2",
}